Objectives:

  1. Mechanism of action in CTLA-4 in mouse and man
  2. Next generation variants of ipilimumab (anti-CTLA-4)
  3. Mechanism of action of negative regulator VISTA
Session date: 
Monday, March 18, 2019 - 12:00pm to 1:00pm
Speaker Name: 
Alan J. Korman, PhD
Location: 
UCMC
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.